or Try an Advanced Search...

    Technical Analysis for AVTX - Avalo Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 12.61 1.12% 0.14
    AVTX closed up 1.12 percent on Monday, July 1, 2024, on 33 percent of normal volume. It was able to find support at its 50 day moving average.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical AVTX trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    50 DMA Support Bullish 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Wide Bands Range Expansion 1.12%
    Overbought Stochastic Strength 1.12%
    NR7 Range Contraction -4.47%
    NR7-2 Range Contraction -4.47%
    Narrow Range Bar Range Contraction -4.47%
    Older End-of-Day Signals for AVTX ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 5 hours ago
    Up 3% about 7 hours ago
    Up 2% about 7 hours ago
    Up 1% about 7 hours ago
    50 DMA Support about 7 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    AVTX Chart by TradingView
    Basic chart:

    Profile

    Avalo Therapeutics is a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. The company has built a diverse portfolio of innovative therapies to deliver meaningful medical impact for patients in urgent need. The company’s clinical candidates commonly have a proven mechanistic rationale, biomarkers and/or an established proof-of-concept to expedite and increase the probability of success.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biology Cancer Immunotherapy Biomarkers Precision Medicine Targeted Therapy Innovative Therapies Rare Genetic Diseases

    Is AVTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 24 Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
    Jun 17 Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
    Jun 6 Avalo Therapeutics files to sell 22.36M shares for holders
    May 13 Avalo Therapeutics reports Q1 results
    May 13 Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
    Apr 2 Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 2 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
    Apr 1 Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
    Apr 1 Avalo Therapeutics EPS of -$114.00, revenue of $1.92M beats by $0.72M
    Mar 29 Avalo Reports 2023 Financial Results and Provides Business Updates
    See more AVTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 95.52
    52 Week Low 3.9501
    Average Volume 38,709
    200-Day Moving Average 14.89
    50-Day Moving Average 12.33
    20-Day Moving Average 11.94
    10-Day Moving Average 12.82
    Average True Range 1.22
    RSI (14) 53.05
    ADX 12.47
    +DI 17.38
    -DI 22.34
    Chandelier Exit (Long, 3 ATRs) 10.33
    Chandelier Exit (Short, 3 ATRs) 13.65
    Upper Bollinger Bands 14.03
    Lower Bollinger Band 9.85
    Percent B (%b) 0.66
    BandWidth 35.02
    MACD Line 0.35
    MACD Signal Line 0.23
    MACD Histogram 0.1232
    Fundamentals Value
    Market Cap 10.11 Million
    Num Shares 802 Thousand
    EPS -480.00
    Price-to-Earnings (P/E) Ratio -0.03
    Price-to-Sales 1.67
    Price-to-Book 0.25
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 15.12
    Resistance 3 (R3) 14.98 14.00 14.70
    Resistance 2 (R2) 14.00 13.36 14.07 14.56
    Resistance 1 (R1) 13.30 12.96 13.65 13.45 14.42
    Pivot Point 12.32 12.32 12.50 12.39 12.32
    Support 1 (S1) 11.63 11.68 11.98 11.77 10.80
    Support 2 (S2) 10.65 11.29 10.72 10.66
    Support 3 (S3) 9.95 10.65 10.52
    Support 4 (S4) 10.10